Anmed Health

Anderson, South Carolina 29621

7 studies enrolling now · 45 studies all time

What they study most

ADHF, ASCVD, Acute Coronary Syndrome, Acute Myocardial Infarction (AMI), Anemia, Angina Pectoris, Arthritis, Rheumatoid, Atherosclerosis, Coronary, Atrial Fibrillation, Atrial Fibrillation (AF), Bleeding, Bleeding Disorder

Studies at this site

• Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure — Recruiting now
• STRIVE Post-Market Registry Study — Recruiting now
• Galvanize Prospective/Retrospective Pulsed Electric Field Device Registry — Recruiting now
• Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation for Whom Oral Anticoagulation is Unsuitable — Recruiting now
• DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD) — Recruiting now
• A Study to Evaluate Solrikitug in Participants With COPD (ZION) — Recruiting now
• Pulmonary Hypertension Association Registry — Recruiting now
• SPYRAL HTN-ON MED Study of Renal Denervation With the Symplicity Spyral™ Multi-electrode Renal Denervation System — Completed
• A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation — Running, not enrolling
• Outcome Study Assessing a 75 Milligrams (mg) Dose of Macitentan in Patients With Pulmonary Arterial Hypertension — Running, not enrolling
• A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome — Completed
• Safety and Effectiveness of the Orsiro Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery Lesions — Completed
• XIENCE Skypoint Large Vessel Post Approval Study — Running, not enrolling
• PIONEER III Trial to Assess Safety and Efficacy of the BuMA Supreme™ Drug Coated Coronary Stent in Patients With Coronary Disease — Completed
• LIFE-BTK Randomized Controlled Trial — Running, not enrolling
• ICoN-1 Phase 3 Study of the Efficacy and Safety of Treatment With MNKD-101, Clofazimine Inhalation Suspension — Stopped early
• PRE-DETERMINE Cohort Study — Running, not enrolling
• Trilaciclib (G1T28) in Patients With Previously Treated Extensive Stage SCLC Receiving Topotecan Chemotherapy — Completed
• Study Comparing Investigational Drug HBI-8000 + Nivolumab vs. Placebo + Nivolumab in Patients With Advanced Melanoma — Running, not enrolling
• A Study of Selexipag Assessing Right Ventricular Remodeling in Pulmonary Arterial Hypertension by Cardiac Magnetic Resonance Imaging — Stopped early
• A Study to Evaluate Whether Macitentan is an Effective and Safe Treatment for Patients With Heart Failure With Preserved Ejection Fraction and Pulmonary Vascular Disease — Completed
• SPYRAL PIVOTAL - SPYRAL HTN-OFF MED Study — Completed
• Understanding Outcomes With the EMBLEM™ S-ICD in Primary Prevention Patients With Low Ejection Fraction — Completed
• Firehawk Rapamycin Target Eluting Coronary Stent North American Trial — Running, not enrolling
• Repository of Phase Signals for Pulmonary Hypertension Algorithm Development — Status unconfirmed
• XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort — Completed
• ABSORB III Randomized Controlled Trial (RCT) — Completed
• A Study to Assess Pulsed Inhaled Nitric Oxide in Subjects With Pulmonary Fibrosis at Risk for Pulmonary Hypertension — Stopped early
• XIENCE 28 USA Study — Completed
• The Cardiovascular Multi-dimensional Observational Investigation of the Use of PCSK9 Inhibitors (cvMOBIUS) — Stopped early
• Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen — Completed
• LEADERS FREE II: BioFreedom™ Pivotal Study — Running, not enrolling
• A Study to Quantify Use of Anticoagulation to Improve Management of Atrial Fibrillation — Stopped early
• A Phase 3, Long-Term Safety Study of Intravenous Epoetin Hospira in Patients With Chronic Renal Failure Requiring Hemodialysis and Receiving Epoetin Maintenance Treatment. AiME - Anemia Management With Epoetin — Completed
• Pressure Injury Prevention in the ICU With Multi-Layer Foam Dressings — Completed
• AngelMed for Early Recognition and Treatment of STEMI — Completed
• The Dual Antiplatelet Therapy Study (DAPT Study) — Completed
• ENDOvascular Interventions With AngioMAX: The ENDOMAX Trial — Stopped early
• The Complete® SE SFA Study for the Treatment of SFA/PPA Lesions — Completed
• Phase III Acute Coronary Syndrome — Stopped early
• Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women — Completed
• SPIRIT PRIME Clinical Trial — Completed
• Access Safety and Efficacy Post Endovascular Intervention — Status unconfirmed
• GRAVITAS: Gauging Responsiveness With A VerifyNow Assay-Impact On Thrombosis And Safety — Completed
• ASP-II: Ancrod Stroke Program: Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke — Stopped early